SAMSUNG PHARM. Co., Ltd. (001360.KS) KSC

Currency In KRW

AD

Valuation

Market Cap144.07B
Enterprise Value150.6B
P/E Ratio-7.15
PEG Ratio0.05
Price/Sales Ratio2.68
Price/Book Ratio0.9
Enterprise/Revenue2.91
Enterprise/EBITDA-16.48

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin-0.39
Operating Margin-0.37
AD

Management Effectiveness

Return On Assets-0.1
Return On Equity-0.11

Income Statement

Revenue46.07B
Revenue/Share464.65
Gross Profit14.64B
EBITDA-18.06B
Net Income11.55B
Diluted EPS122.66

Balance Sheet

Total Cash13B
Total Cash/Share138.12
Total Debt18.15B
Total Debt/Equity0.14
Current Ratio0.96
Book Value Per Share1,379.22

Price History

52-Week Change-25.48
52-Week High2,320
52-Week Low1,230
Moving Average 50 Days1,532.84
Moving Average 200 Days1,652.25

Statistics

Average Volume1.24M
Shares Outstanding94.12M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1093:1000
Last Split DateMay 02, 2018
AD